AG(ANSA) – BOLOGNA, SEPTEMBER 30 – “Chiesi’s strategy is fully aligned with European priorities: our investment in the creation of the Biotech Center of Excellence, therefore in the future of medicine, contributes to strengthening the national and European biotech ecosystem , making our country and our continent more competitive. By working together with the institutions and other stakeholders we can guarantee European citizens access, without delay, to cutting-edge therapies and guarantee biopharmaceutical innovation in Europe”. This was stated by Alessandro Chiesi, president of the Parma pharmaceutical group, commenting in a note on the inauguration of the Biotech Center of Excellence in the Emilian city.
“The opening of our new Biotech Center of Excellence represents a significant step forward in our commitment to developing revolutionary therapies that concretely improve patients’ quality of life – underlines CEO Giuseppe Accogli – This modern hub at European level allows us to accelerate the our transformation journey, towards a future represented by biotechnology. The Biotech Center of Excellence will raise our production capabilities to new levels and allow us to promote collaborations to better respond to the needs of patients globally, especially in a therapeutic area such as of rare diseases”. AG(ANSA).
2024-09-30 16:36:55